These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28541601)

  • 21. Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Burzotta F; Summaria F; Latib A; De Vita M; Fantoni C; Benedetto S; Turturo M; Larosa C; Manzoli A; Trani C
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):15-22. PubMed ID: 25914397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.
    De Filippo O; D'Ascenzo F; Angelini F; Franchin L; Cerrato E; Pennacchi M; Nuñez-Gil I; Wojakowski W; Imori Y; Trabattoni D; Huczek Z; Venuti G; Muscoli S; Iannaccone M; Montabone A; Marengo G; Rognoni A; Parma R; Figini F; Mitomo S; Boccuzzi G; Mattesini A; Quadri G; Wańha W; Smolka G; Rolfo C; Cortese B; Ryan N; Capodanno D; Chieffo A; di Mario C; Varbella F; Romeo F; Sheiban I; Escaned J; Helft G; De Ferrari GM
    J Invasive Cardiol; 2021 Nov; 33(11):E890-E899. PubMed ID: 34735352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 12-month intravascular ultrasound observations from BiOSS® first-in-man studies.
    Gil RJ; Bil J; Costa RA; Gil KE; Vassiliev D
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1339-1347. PubMed ID: 27314841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mid-term outcomes after percutaneous interventions in coronary bifurcations.
    Zimarino M; Briguori C; Amat-Santos IJ; Radico F; Barbato E; Chieffo A; Cirillo P; Costa RA; Erglis A; Gamra H; Gil RJ; Kanic V; Kedev SA; Maddestra N; Nakamura S; Pellicano M; Petrov I; Strozzi M; Tesorio T; Vukcevic V; De Caterina R; Stankovic G;
    Int J Cardiol; 2019 May; 283():78-83. PubMed ID: 30528620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-year results of BiOSS stents in coronary bifurcation treatment.
    Gil RJ; Kern A; Formuszewicz R; Iñigo Garcia LA; Dobrzycki S; Vassilev D; Bil J
    Eur J Clin Invest; 2021 Aug; 51(8):e13555. PubMed ID: 33782985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
    Chen SL; Sheiban I; Xu B; Jepson N; Paiboon C; Zhang JJ; Ye F; Sansoto T; Kwan TW; Lee M; Han YL; Lv SZ; Wen SY; Zhang Q; Wang HC; Jiang TM; Wang Y; Chen LL; Tian NL; Cao F; Qiu CG; Zhang YJ; Leon MB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1266-76. PubMed ID: 25326748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results.
    Gil RJ; Kern A; Bojko K; Gziut-Rudkowska A; Vassilev D; Bil J
    Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry.
    Gil RJ; Kern A; Pawłowski T; Bil J
    Arch Med Sci; 2023; 19(2):324-330. PubMed ID: 37034511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study.
    Kawamoto H; Chieffo A; D'Ascenzo F; Jabbour RJ; Naganuma T; Cerrato E; Ugo F; Pavani M; Varbella F; Boccuzzi G; Pennone M; Garbo R; Conrotto F; Biondi-Zoccai G; D'Amico M; Moretti C; Escaned J; Gaita F; Nakamura S; Colombo A
    Int J Cardiol; 2018 Jan; 250():80-85. PubMed ID: 28992999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.
    Gil RJ; Bil J; Michałek A; Vassiliev D; Costa RA
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1667-76. PubMed ID: 23868287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?
    Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W
    J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Upfront Two-Stent Strategy for True Coronary Bifurcation Lesions with A Large Side Branch in Acute Coronary Syndrome: A Two-Year Follow-Up Study.
    Yurtdaş M; Asoğlu R; Özdemir M; Asoğlu E
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32121323
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Hiromasa T; Kobayashi Y; Morinaga T; Yamaji K; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):E132-E138. PubMed ID: 26708085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DK mini-culotte stenting in the treatment of true coronary bifurcation lesions: a propensity score matching comparison with T-provisional stenting.
    Fan L; Chen L; Luo Y; Zhang L; Zhong W; Lin C; Chen Z; Peng Y; Zhen X; Dong X
    Heart Vessels; 2016 Mar; 31(3):308-21. PubMed ID: 25515667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year clinical outcome of percutaneous coronary intervention with very long (≥ 40mm) drug-eluting stent.
    Rajesh GN; Sulaiman S; Vellani H; Sajeev CG
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S285-S289. PubMed ID: 30595276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population.
    Gil RJ; Vassilev D; Michalek A; Kern A; Formuszewicz R; Dobrzycki S; Wójcik J; Lesiak M; Kardaszewicz P; Lekston A
    EuroIntervention; 2012 Jul; 8(3):316-24. PubMed ID: 22829507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.